Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
175 participants
OBSERVATIONAL
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
What is the Optimal Follow-up for Patients With Systemic Sclerosis?
NCT05103553
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594
Study of Silicone-Associated Connective Tissue Diseases
NCT00001330
Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
NCT04132206
Calcinosis in a Single-Center Scleroderma Population
NCT02062125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SSc
Sacroiliitis
No interventions assigned to this group
Rheumatoid arthritis
Sacroiliitis
No interventions assigned to this group
Healthy controls
Sacroiliitis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cukurova University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Didem Arslan Tas
Internist and rheumatologist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05/01/2012-4/21
Identifier Type: OTHER
Identifier Source: secondary_id
Sacroiliitis in SSc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.